Filing Flows › Pulse Biosciences (PLSE) › Stock forecast & fair value
Pulse Biosciences (PLSE) stock forecast and price target
Pulse Biosciences (PLSE) trades at $53.29. 6 analysts' median price target is $67.50 (+27%), from $58.00 to $74.00.
Pulse Biosciences' latest quarter
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for PLSE stock?
The median of 6 analysts' 12-month targets is $67.50, +27% from $53.29; the range is $58.00 to $74.00. The average rating is none.
Does Pulse Biosciences usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is PLSE stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.